Menu
Back to Archived Journals » Research and Reports in Transdermal Drug Delivery » Volume 1
Transdermal drug delivery: approaches and significance
Authors Murthy S
Received 13 March 2012
Accepted for publication 13 March 2012
Published 3 May 2012 Volume 2012:1 Pages 1—2
S Narasimha Murthy
Department of Pharmaceutics, The University of Mississippi, USA
Transdermal drug delivery systems deliver drugs through the skin as an alternative to oral, intravascular, subcutaneous, and transmucosal routes. Potential advantages of transdermal delivery include, but are not limited to, elimination of first-pass metabolism, steady delivery/blood levels, better patient compliance, reduced systemic drug interactions, possible dose intervention, avoidance of medically assisted drug administration, prolonged drug administration, and overall better therapeutic efficacy.
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.